A Study of GSK5926371 in Participants With B-cell Driven Autoimmune Rheumatic Diseases (ARD)

Clinical trial NCT07371468 · RECRUITING

Trial details

NCT number: NCT07371468
Sponsor: GlaxoSmithKline
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Systemic Lupus Erythematosus

Start date: 2026-02-10
Primary completion: 2028-03-15
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.